Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2022
EpiVax establishes the Vax Gives Back Fund with Rhode Island Foundation
EpiVax announced the establishment of the Vax Gives Back Fund at the Rhode Island Foundation. The fund sets aside a yearly budget for EpiVax employees to distribute to local nonprofit organizations.
2020
EpiVax out-licenses COVID-19 vaccine candidate to EpiVax Therapeutics
EpiVax announced that it had out-licensed its COVID-19 vaccine candidate, EPV-CoV-19, to EpiVax Therapeutics.
2020
EpiVax licenses ISPRI toolkit to AbCellera
EpiVax announced that it licensed its ISPRI in silico immunogenicity screening toolkit to AbCellera, which plans to use it in its antibody discovery programs.
2020
eTheRNA announces international consortium for CoV-2 vaccine development
eTheRNA announced that it had formed a consortium with North American and European partners to develop an mRNA vaccine against CoV-2. The announcement also said preclinical development had started.
2020
EpiVax and University of Georgia collaborate on COVID-19 vaccine project
EpiVax announced a collaboration with University of Georgia vaccine expert Ted Ross to accelerate efforts to create a vaccine against COVID-19. The two organizations also applied to the National Institutes of Health for additional project funding.